Basophil-fibroblast signals driving inflammation in atopic dermatitis
Official title: Investigating a basophil-fibroblast pro-inflammatory axis in atopic dermatitis
Funded at Icahn School of Medicine at Mount Sinai · NIH-11367733 · Data updated 2026-11-12
A study in mouse models and human tissue samples looks at how basophils and fibroblasts talk to each other to fuel skin inflammation in atopic dermatitis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 2, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $544,559 |
| NIH project number | 1R01AR086189-01A1 |
| Project ID | NIH-11367733 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with atopic dermatitis or related inflammatory skin conditions, or those who could provide human skin samples for comparative analysis.
✕Less likely to help
Patients without atopic dermatitis or those not contributing tissue samples may not benefit directly.
What this research studies
This project investigates how basophils release signals like IL-4/IL-13 and OSM that may activate skin fibroblasts to produce inflammatory chemicals. By using genetic approaches to reduce basophil activity and their signals in AD-like inflammation, the team will see if overall skin inflammation decreases and fibroblast inflammatory features lessen. The study also examines how activated fibroblasts recruit immune cells and worsen skin disease, linking cellular conversations to symptoms. Findings from mouse models will be compared to human tissue data to gauge relevance to people with atopic dermatitis.
Why it matters
Potential benefit: Understanding this pathway could lead to new treatments that dampen skin inflammation in atopic dermatitis.
How similar studies have gone: Preclinical models have shown basophil-fibroblast interactions can drive inflammatory signals, with human data suggesting similar patterns in AD tissues.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Ji, Andrew — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ji, Andrew
Related research
Other NIH-funded projects on the same topics.
-
Stopping Atopic Dermatitis and Allergy: Preventing Food Allergy by Protecting the Skin
A large study in infants at high risk for allergies tests whether using a skin barrier cream together with early, proactive skin care can prevent peanut allergy and other food allergies.
-
SEAL Study: Preventing peanut allergy by protecting baby skin
This trial tests whether using a skin-emollient and proactive skin steroids early in life can prevent peanut allergy in high-risk infants.
-
SEAL Study: Prevent allergy by protecting the baby’s skin
A very young group of high-risk babies will try a early skin-care plan to reduce eczema and prevent peanut allergy.
-
Understanding how skin fungi affect atopic dermatitis in adults
A study will look at how the skin's fungal community influences atopic dermatitis in adults and whether this understanding could lead to new treatments.
-
Preventing eczema-related allergies by strengthening infants' skin barrier
This project will see if using a trilipid skin cream plus proactive mild topical steroids in infants with early dry skin or eczema lowers their chances of developing food allergies.
-
Personalized predictions for how atopic dermatitis may progress in kids and teens
A patient-friendly plan to forecast how early-onset eczema might evolve in children and young people using simple health clues and data from diverse settings.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.